Las Condes Clinic Completes First Stage of Capital Increase and Reaffirms Financial Sustainability
2 Articles
2 Articles
Clínica Las Condes (CLC) reported this Thursday that it concluded the first stage of its capital increase process, an operation agreed at the extraordinary shareholders' meeting of January 30, at a subscription price of $10,000 per share. It specified that during the preferred option period 88.7% of the shares available were subscribed, collecting $70,971 million. At that meeting, the issue of 8 million new shares was approved.
The general manager of CLC, Pablo Yarmuch, appreciated the reception of the process: “We appreciate the support of our shareholders to this first stage. This increase in capital allows us to advance our vision of being the most reliable health institution in Chile: a clinic that cares for and heals with excellence, accessible and connected with its patients.”

Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
